Jamie L Lesnock

Summary

Publications

  1. doi Palliative care education in gynecologic oncology: a survey of the fellows
    J L Lesnock
    Mid Atlantic Gynecologic Oncology of Mon General Hospital, Morgantown, WV 26505, USA
    Gynecol Oncol 130:431-5. 2013
  2. doi Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis
    Jamie L Lesnock
    Mid Atlantic Gynecologic Oncology of Mon General Hospital, Morgantown, WV 26505, USA
    Gynecol Oncol 129:574-9. 2013
  3. doi Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes
    Malgorzata E Skaznik-Wikiel
    Division of Gynecologic Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Int J Gynecol Cancer 22:232-7. 2012
  4. doi Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levels
    Scott D Richard
    Division of Gynecologic Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Int J Gynecol Cancer 20:932-5. 2010
  5. pmc Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer
    Jamie L Lesnock
    Dept of ObGyn, Division of Gynecologic Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Gynecol Oncol 122:473-8. 2011
  6. doi Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications
    Jamie L Lesnock
    Division of Gynecologic Oncology, Magee Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Gynecol Oncol 116:345-50. 2010

Collaborators

Detail Information

Publications6

  1. doi Palliative care education in gynecologic oncology: a survey of the fellows
    J L Lesnock
    Mid Atlantic Gynecologic Oncology of Mon General Hospital, Morgantown, WV 26505, USA
    Gynecol Oncol 130:431-5. 2013
    ..We sought to examine the training provided to gynecologic oncology fellows as well as their perceived preparedness to provide palliative care...
  2. doi Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis
    Jamie L Lesnock
    Mid Atlantic Gynecologic Oncology of Mon General Hospital, Morgantown, WV 26505, USA
    Gynecol Oncol 129:574-9. 2013
    ..Radiation can be delivered via four-field box (BOX-RT) or intensity modulated radiation therapy (IMRT). We sought to evaluate the cost-effectiveness (C/E) of IMRT relative to BOX-RT for the treatment of locally advanced cervical cancer...
  3. doi Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes
    Malgorzata E Skaznik-Wikiel
    Division of Gynecologic Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Int J Gynecol Cancer 22:232-7. 2012
    ..The purpose of this study was to determine outcomes, completion rates, and frequency of complications in patients with platinum-sensitive recurrent EOC treated with IP chemotherapy...
  4. doi Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levels
    Scott D Richard
    Division of Gynecologic Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Int J Gynecol Cancer 20:932-5. 2010
    ..We hypothesize that patients undergoing IP chemotherapy may have elevated CA125 values when compared with patients receiving intravenous (IV) chemotherapy...
  5. pmc Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer
    Jamie L Lesnock
    Dept of ObGyn, Division of Gynecologic Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Gynecol Oncol 122:473-8. 2011
    ..We sought to evaluate the cost-effectiveness (C/E) of these consolidation strategies...
  6. doi Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications
    Jamie L Lesnock
    Division of Gynecologic Oncology, Magee Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Gynecol Oncol 116:345-50. 2010
    ..We sought to evaluate the effect of dose modification of IP therapy on completion rates...